These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Use of strophanthin in the acute period of myocardial infarct]. Tolstopiatov SM Vrach Delo; 1980 Sep; (9):54-7. PubMed ID: 7423952 [No Abstract] [Full Text] [Related]
47. [Side effects of non-venous administration of strophantin]. STEIDLE R Med Klin; 1953 Feb; 48(7):209-11. PubMed ID: 13119281 [No Abstract] [Full Text] [Related]
48. [On the method of small-drop intravenous perfusion of strophanthin]. Val'dman VA Kardiologiia; 1968 Jan; 8(1):108-11. PubMed ID: 5654226 [No Abstract] [Full Text] [Related]
49. [On the quantitative effectiveness of k-strophanthin-alpha (Cymarin) in intravenous and oral administration]. Storz H Dtsch Med Wochenschr; 1969 May; 94(22):1166-9. PubMed ID: 5768542 [No Abstract] [Full Text] [Related]
50. [On the improvement of the oral strophantin therapy]. MUTSCHLER P Med Klin; 1952 Dec; 47(50):1656-7. PubMed ID: 13024694 [No Abstract] [Full Text] [Related]
51. [On improved oral therapy with strophantin]. LENZ W Dtsch Med Wochenschr; 1953 Aug; 78(35):1170-1. PubMed ID: 13083214 [No Abstract] [Full Text] [Related]
52. [Electroca rdiographic control in clinical use of mean therapeutic doses of cardiac glycosides (strophanthin, corglycon)]. Fan-Tkhi-Ngok-Shiong Ter Arkh; 1974; 46(6):83-9. PubMed ID: 4473844 [No Abstract] [Full Text] [Related]
53. [Use of strophanthin in the acute period of myocardial infarct (study of hemodynamics)]. Oberemchenko IaV; Zasedatelev VK Ter Arkh; 1978; 50(8):16-20. PubMed ID: 694755 [No Abstract] [Full Text] [Related]
54. [Elimination of H 3 -g-strophanthin by hemodialysis]. Kramer P; Horenkamp J; Quellhorst E; Scheler F Klin Wochenschr; 1970 Feb; 48(3):148-9. PubMed ID: 5523128 [No Abstract] [Full Text] [Related]
55. [About the results of rectal strophanthine treatment]. PIES E Klin Prax; 1946 May; 1(9):156-9. PubMed ID: 20287126 [No Abstract] [Full Text] [Related]
56. [Treatment with strophantin microclyster]. WOLFFENBUTTEL E Rev Bras Med; 1955 Oct; 12(10):747-8. PubMed ID: 13336572 [No Abstract] [Full Text] [Related]
57. [Effectiveness of various strophanthin doses in the emergency therapy of paroxysms of atrial fibrillation and flutter]. Anshelevich IuV; Sorokina TA; Orlova VP Klin Med (Mosk); 1981 Jun; 59(6):80-4. PubMed ID: 7289509 [No Abstract] [Full Text] [Related]
58. [Clinical evaluation of the combination of strophanthin and ATP in the therapy of chronic circulatory insufficiency]. Karbasnikova GN Sov Med; 1974 Aug; 0(8):90-4. PubMed ID: 4428283 [No Abstract] [Full Text] [Related]
59. [Digitalic activity following rectal administration]. RAYMOND-HAMET C R Seances Soc Biol Fil; 1955 Jul; 149(13-14):1395-7. PubMed ID: 13293864 [No Abstract] [Full Text] [Related]
60. [On the strophoral dispute]. HEILMEYER L Munch Med Wochenschr; 1952 Feb; 94(5):207-9. PubMed ID: 14919450 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]